Clinical trial Recruiting at 1 site Observational Ages 18 and up

Craving and addiction severity: how craving links to changing levels of addiction in daily life

Official title: Symptom Networks Characteristics and Centrality of Craving as Markers of Transition Across Levels of Addiction Severity: A Longitudinal Study

Run by University of Bordeaux · NCT07734363 · Data updated 2026-11-12

This observational study tests whether craving and the way different addiction symptoms interact can predict changes in addiction severity over two years for adults with substance use disorders.

More Addiction trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment700 (estimated)
SponsorUniversity of Bordeaux
Academic / other
Locations1 site (Bordeaux)
StatusRecruiting
StartedMay 20, 2026
Main results expectedDecember 2030
Study endsJune 2031
Registry record updatedJuly 29, 2026
Trial IDNCT07734363 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults who identify a primary substance with regular use (at least twice weekly) and a current DSM-5 SUD diagnosis.

Probably not a fit

Individuals without a primary substance use disorder or those unable to comply with smartphone-based data collection may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This longitudinal observational study follows adults with a primary substance use disorder to see how craving relates to other symptoms over time. Researchers will collect daily life data using ecological momentary assessment and perform annual DSM-5 evaluations, focusing on symptom networks, centrality of craving, and how these relate to severity trajectories. They will also examine a wide range of demographic, cognitive, psychological, and quality-of-life factors to identify predictors of progression. Analyses will include correlations and regression models at baseline, 1-year, and 2-year follow-ups in order to characterize trajectories of addiction severity.

Why it matters

Potential benefit: If successful, findings could help identify early markers of worsening severity and inform personalized monitoring or intervention strategies.

How similar studies have gone: Similar approaches using symptom networks and craving have shown promise in understanding addiction dynamics, but this exact longitudinal network analysis is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Be over 18 years of age
* Identify a primary substance as a main problematic substance use.
* Be a regular user (at least twice a week in the last 30 days) of a primary substance (defined as their main problematic substance use).
* Present a current diagnosis of SUD for this primary substance according to DSM-5 criteria.

Exclusion Criteria

* Medical, psychiatric or addiction condition that warrants immediate inpatient treatment intervention.
* Somatic, cognitive or other disorders preventing the use of the smartphone device (deafness, impaired vision, illiteracy….).
* Not being familiar with the use of smartphone
* Having a smartphone not compatible with the application and being unable to visit the laboratory to receive a loaner phone for the study.
* Difficulty in understanding and/or writing and/or reading French.
* Individuals participating in another study that includes an ongoing exclusion period.
* Be deprived of liberty due to an ongoing legal procedure.
* Be under legal protection.
* Be under guardianship or conservatorship.

Where it's running

  • Université de Bordeaux CNRS UMR 6033 SANPSY
    Bordeaux, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.